The Health Profile of England, showing the full extent of public health improvements in recent years and highlights the problems that we continue to face. Health Challenge England – next steps for the selection of health puts public health achievements since 2004 and the next stage of the program of action.
Quarter of 2009. Begins dosing in Phase II clinical trial of ANA598 – Anadys completed dosing in two long-term chronic toxicology studies of ANA598 was. At the 13-week interim, the toxicology profile ANA598 in both species low low. A preliminary analysis of results from the 26-week rat study shows a similar profile in rats after 13 weeks seen in which the only side effect was finding a marginal decline in the rate of weight gain in females at 1000 mg / kg, the highest dose tested. The full results from both studies, including 39 – week data from the monkey study at the end at the end of the third quarter of 2009. Continue reading “The Health Profile of England.”